Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis.
A five-center collaborative study was undertaken to determine the suitability of the Phadebact CSF test kit and the Phadebact group B Streptococcus reagent for routine use by clinical laboratories to detect antigens of common organisms causing bacterial meningitis. The kits employ staphylococcal protein A coagglutination to detect the antigens of Haemophilus influenzae types a, b, c, d, e, and f, Neisseria meningitidis groups A, B, C, Y, and W135, Streptococcus pneumoniae (83 serotypes), and group B Streptococcus. A total of 2,817 individual tests were performed on 577 cerebrospinal fluid specimens. The percent positive specimens detected by coagglutination was as follows: overall, 84%; H. influenzae, 97%; group B Streptococcus, 75%; S. pneumoniae, 71%; and N. meningitidis, 58%. Eighty-five of the specimens were also tested by counterimmunoelectrophoresis. Coagglutination was more sensitive than counterimmunoelectrophoresis because it detected 74% of the positive specimens, whereas counterimmunoelectrophoresis detected only 65%. No false-positive results were obtained with coagglutination. The Phadebact CSF test kit is recommended for routine use in screening cerebrospinal fluid samples for antigens of the common organisms causing bacterial meningitis along with the Gram stain and culture for delayed confirmation of the rapid results.
D000372:Agglutination Tests; D000942:Antigens, Bacterial / Q000032:analysis; D005069:Evaluation Studies as Topic; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D008581:Meningitis / Q000134:cerebrospinal fluid* / Q000382:microbiology; D009345:Neisseria meningitidis / Q000276:immunology; D011933:Reagent Kits, Diagnostic; D013205:Staphylococcal Protein A; D013292:Streptococcus agalactiae / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology
D000942:Antigens, Bacterial; D011933:Reagent Kits, Diagnostic; D013205:Staphylococcal Protein A